Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Futura Medical, Serco

Sun 16 Jul 2023 12:33

(Sharecast News) - The Sunday Times's Lucy Tobin told readers that shares of Futura Medical were worth a punt, even if there were no guarantees of a happy ending.

Although the company had just 14 staff and directors, it had a new product that worked, Eroxon, a gel for those suffering from erectile dysfunction, which did not require a prescription in order to be sold.

Given that the market for ED was expected to surpass $6bn in value by 2032, the business's future looked appealing.

And unlike rival products Viagra and Cialis, both of which required a prescription, Eroxon took just 10 minutes to work, not half an hour.

The company was expecting approval for Eroxon in Saudi Arabia in September and was working on having a US partner for commercialisation which would likely a surge in the share price.

"There are no guarantees of a happy ending, but it's a worthy punt. Buy."

The Financial Mail on Sunday's told readers to 'buy' shares of Serco, although it conceded that risks were not absent.

The outsourcer was well-placed to benefit form government outlays on immigration and defence in many regions of the world, the tipster argued.

On the flip-side, there were multiple potential risks.

For starters, making up the loss of Covid-related work "wasn't always easy".

Furthermore, the possibility existed that it might lose the Australian immigration contract that was up for renewal in 2023.

Serco also had a tendency to work in "high-profile" and "controversial" areas, including on immigration which in the past had led to scandal and had an extremely negative impact on its share prices.

"There's no suggestion that the current management is likely to lead the company into any problems like this though, since former chief executive Rupert Soames is credited with shaking out any problems at the business, leaving it in stronger shape.

"At 156p, the shares are a buy."

Share this article

Related Sharecast Articles

Wed 30 Sep 2026 07:08
Wednesday newspaper round-up: BrewDog, Barclays, Grant Thornton
(Sharecast News) - BrewDog's new owner has urged drinkers to give the ailing brand "a second chance" as it invests more than £50m in improving the company's beers, pubs and working conditions. The US cannabis and drinks company Tilray bought BrewDog for £33m in March this year, after the company collapsed into administration after five years of losses and a series of controversies relating to the treatment of workers under the founder James Watt. - Guardian
Tue 29 Sep 2026 07:02
Tuesday newspaper round-up: BT, borrowings costs, RBA, tariffs
(Sharecast News) - BT has been blocked from offering rival broadband providers discounted access to its network over concerns that the plans would threaten competition. Openreach, BT's infrastructure division, proposed discounts of up to £9.50 per month to companies such as Vodafone, Sky and TalkTalk for using its broadband network. It had said this would allow broadband providers to offer households value for money. - Telegraph
Mon 28 Sep 2026 07:09
Monday newspaper round-up: Heathrow, diesel cars, empty homes
(Sharecast News) - Plans for a third runway at Heathrow are once again up in the air after the prime minister refused to say whether he backs the "contested" project which is delayed by up to four years. Over the weekend it emerged that ​Heathrow no longer expects to meet the original 2035 deadline. Instead, the airport hopes to secure planning permission by 2029 and then open the runway "within a decade", meaning it would not be operational until 2039. - Guardian
Fri 25 Sep 2026 07:10
Friday newspaper round-up: Food and drink trade deficit, datacentre project, Meta, Morgan Stanley
(Sharecast News) - The gap between Britain's food and drink exports and imports has neared its highest this century, as a combination of Brexit, war in the Middle East and US tariffs dented deliveries overseas while imports soared. The UK's food and drink trade deficit has risen to more than £21bn - the largest since 2000 - in what industry leaders said was a "wake-up call" for the government to protect homegrown produce in the interest of national security. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026